Introduction
Intracort IM/IA Injection 40 mg/ml is a corticosteroid medication used to treat a wide range of inflammatory conditions. It is commonly used to reduce swelling, redness, and itching in conditions such as arthritis, dermatitis, and allergies.Uses For
Intracort IM/IA Injection 40 mg/ml is used to treat various inflammatory and allergic conditions such as:- Arthritis
- Asthma
- Allergic reactions
- Dermatitis
- Inflammatory bowel disease
- Lupus
| Brand Name | Intracort |
|---|---|
| Type | IM/IA Injection |
| Weight | 40 mg/ml |
| Generic | Triamcinolone Acetonide (Injection) |
| Manufacturer | Novatek Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Mechanism of Action
Intracort IM/IA Injection 40 mg/ml works by blocking inflammatory mediators, such as histamine, which cause irritation, redness, and itching. It also inhibits the production of prostaglandins, which are substances that are released by the body in response to injury or irritation.How Long Does It Take To Work?
The effects of Intracort IM/IA Injection 40 mg/ml can be felt within a few hours after administration, but the full effects may take several days to be fully realized.Absorption
Intracort IM/IA Injection 40 mg/ml is quickly and completely absorbed into the bloodstream after injection.Route of Elimination
Intracort IM/IA Injection 40 mg/ml is metabolized in the liver and is excreted in the urine and bile.Dosage
General- Dosage: The initial dose of Triamcinolone injection may vary from 2.5 mg to 100 mg per day depending on the specific disease entity being treated. However, in certain overwhelming, acute, life-threatening situations, administration in dosages exceeding the usual dosages may be justified. Dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.
- Administration: Strict aseptic technique is mandatory. The vial should be shaken before use to ensure a uniform suspension. Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
- Dosage: The suggested initial dose is 60 mg, injected deeply into the gluteal muscle. Atrophy of subcutaneous fat may occur if the injection is not properly given. Dosage is usually adjusted within the range of 40 mg to 80 mg, depending upon patient response and duration of relief. However, some patients may be well controlled on doses as low as 20 mg or less. Pediatric patients: The range of initial doses is 0.11 to 1.6 mg/kg/day in 3 or 4 divided doses.
- Administration: For systemic therapy, injection should be made deeply into the gluteal muscle. For adults, a minimum needle length of 11/2 inches is recommended. In obese patients, a longer needle may be required. Use alternative sites for subsequent injections.
- Dosage: Intra-articular administration: A single local injection of Triamcinolone Acetonide is frequently sufficient, but several injections may be needed for adequate relief of symptoms. Initial dose: 2.5 mg to 5 mg for smaller joints and from 5 mg to 15 mg for larger joints, depending on the specific disease entity being treated. For adults, doses up to 10 mg for smaller areas and up to 40 mg for larger areas have usually been sufficient. Single injections into several joints, up to a total of 80 mg, have been given.
- Administration: For treatment of joints, the usual intra-articular injection technique should be followed. If an excessive amount of synovial fluid is present in the joint, some, but not all, should be aspirated to aid in the relief of pain and to prevent undue dilution of the steroid.
Administration
Intracort IM/IA Injection 40 mg/ml is administered intramuscularly (IM) or intravenously (IV). It is important to follow the dosage instructions given by the physician. The injection should be given slowly and deeply.Side Effects
Common side effects of Intracort IM/IA Injection 40 mg/ml may include:- Weight gain
- Swelling
- Insomnia
- Nausea
- Stomach pain
- Headache
- Dizziness
- Diarrhea
- Anxiety
- Irritability
- Aggression
- Severe itching
- Hives or a rash
- Blurred vision
Toxicity
Intracort IM/IA Injection 40 mg/ml is generally safe when used as directed. High doses or prolonged use may increase the risk of side effects, including liver toxicity.Precaution
Patients receiving Intracort IM/IA Injection 40 mg/ml should be monitored closely for changes in blood pressure, blood sugar, electrolyte levels, and liver enzymes. This medication should not be used if the patient is pregnant, lactating, or trying to conceive a child, as it may be harmful to the fetus or newborn.Interaction
Intracort IM/IA Injection 40 mg/ml may interact with other medications, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Be sure to inform the physician of any medications, vitamins, or supplements that are being taken prior to receiving Intracort IM/IA Injection 40 mg/ml.Disease Interaction
People with certain medical conditions should not use Intracort IM/IA Injection 40 mg/ml. These include:- Active infections
- Diabetes
- Epilepsy
- Heart, liver, or kidney diseases
- High blood pressure
- Mental illness
- Osteoporosis
- Tuberculosis
Drug Interaction
Intracort IM/IA Injection 40 mg/ml may interact with other medications, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Be sure to inform the physician of any medications, vitamins, or supplements that are being taken prior to receiving Intracort IM/IA Injection 40 mg/ml.Food Interactions
No food interactions have been reported with the use of Intracort IM/IA Injection 40 mg/ml.Pregnancy Use
Intracort IM/IA Injection 40 mg/ml should not be used during pregnancy, as it may be harmful to the fetus or newborn baby.Lactation Use
Intracort IM/IA Injection 40 mg/ml should not be used while nursing, as it may pass into breast milk and cause harm to the baby.Acute Overdose
An acute overdose of Intracort IM/IA Injection 40 mg/ml is not expected to be life-threatening. Symptoms of an overdose may include nausea, vomiting, confusion, severe headaches, blurred vision, dizziness, tremors, and seizures. If an overdose is suspected, the physician should be contacted immediately.Contraindication
Intracort IM/IA Injection 40 mg/ml should not be used by people with a history of hypersensitivity or an allergic reaction to any of its components.Use Directions
Intracort IM/IA Injection 40 mg/ml should be used according to individual physician's directions and according to the patient's age, weight, and medical condition. The injection should be given slowly and deeply into the muscle and should not be injected intravenously.Storage Conditions
Intracort IM/IA Injection 40 mg/ml should be stored in a tightly sealed container at room temperature, away from moisture and heat, and protected from light.Volume of Distribution
Intracort IM/IA Injection 40 mg/ml has a volume of distribution of 1.76-2.05 L/kg.Half Life
The half-life of Intracort IM/IA Injection 40 mg/ml is 0.78-1.47 hours.Clearance
Intracort IM/IA Injection 40 mg/ml has an oral clearance of 0.31-1.27 L/h/kg.See in details version Intracort IM/IA Injection 40 mg/ml also Intracort IM/IA Injection 40 mg/ml in bangla
Some Frequently Asked Questions About Intracort IM/IA Injection 40 mg/ml
*** Taking medicines without doctor's advice can cause long-term problems.
Related Medicines